Correction: Aiforia Technologies Plc – Managers’ Transactions

Aiforia Technologies Plc CORRECTION RELEASE, MANAGERS’ TRANSACTIONS 04 January 2023 02:00 p.m. EEST 

Aiforia Technologies Plc  corrects the company release published on 29 December 2022 at 03:00 p.m. EEST. In the original company release, the unit price concerning transaction details and aggregated transactions was 68.62 euros. Volume concerning transaction details and aggregated transactions was 100. The correct unit price is 1.3724 euros and volume 5000.
 
In addition, the subscriptions are subject to the approval of the Board of Directors of Aiforia Technologies Plc.
 
Below the release with the correct outlook.

____________________________________________

Person subject to the notification requirement
Name: Veli-Matti Parkkonen
Position: Chief Financial Officer

Issuer: Aiforia Technologies Oyj
LEI: 743700TJRVBX7420Y723
Notification type: INITIAL NOTIFICATION
Reference number: 22901/5/4
____________________________________________

Transaction date: 2022-12-27
Venue not applicable
Instrument type: DERIVATIVE
Instrument name: Aiforia Technologies Oyj Optio ohjelma 2021 IV
Nature of the transaction: EXERCISE OF A STOCK OPTION

Transaction details
(1): Volume: 5000 Unit price: 1.3724 EUR

Aggregated transactions
(1): Volume: 5000 Unit price: 1.3724 EUR

The subscriptions are subject to the approval of the Board of Directors of Aiforia Technologies Plc.

Further inquiries 
 
Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc, tel. +358405009878
https://investors.aiforia.com/  
 
Certified Adviser 
 
UB Securities Ltd, tel. +358 9 25 380 225  
 
About Aiforia 
 
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud-based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more. Find out more: www.aiforia.com